Australian Rheumatology Association ASM 2025 Conference Review

In this edition:

Hypnotherapy for chronic pain & fibromyalgia
Arthritis risk living near blue/green spaces
Walking & hip/knee OA pain/function
TikTok perspectives on targeted therapy & biologics in RA/psoriatic arthritis
Time to response with bimekizumab in axSpA
High BMI in Australian fibromyalgia patients
Patient decision-making in chronic inflammatory diseases
Time to first appointment & DMARDs in suspected RA
Cancer prevalence in rheumatological diseases
AI to identify new risk factors for RA
 

Please login below to download this issue (PDF)

Subscribe